The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million multiple-award Federal Supply Schedule contract with the VA for tissue regeneration products, and a $49.5 million multiple-award Indefinite Delivery Contract with the DLA Troop Support Medical for wound care dressings and medical supplies. These contracts demonstrate Organogenesis' strong presence in supplying regenerative medicine solutions to government healthcare programs, supporting medical treatments for military personnel and veterans.
Generated 3/24/25, 9:45 AM